Furthermore, IL-1R1 blockade was found to alleviate psoriatic skin inflammation, decrease Cxcl2 expression, and diminish neutrophilia, suggesting that IL-1β dysregulation due to autophagy deficiency plays an important role in psoriasis pathogenesis by driving neutrophilic inflammation (Fig. 8). Here, CXCL2 is linked to psoriasis.